- Home
- IOBT vs FCO Comparison
IOBT vs FCO Comparison
Compare IOBT & FCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOBT
- FCO
- Stock Information
- Founded
- IOBT 2014
- FCO 1991
- Country
- IOBT Denmark
- FCO United Kingdom
- Employees
- IOBT N/A
- FCO N/A
- Industry
- IOBT Biotechnology: Pharmaceutical Preparations
- FCO Investment Managers
- Sector
- IOBT Health Care
- FCO Finance
- Exchange
- IOBT Nasdaq
- FCO Nasdaq
- Market Cap
- IOBT 79.7M
- FCO 84.2M
- IPO Year
- IOBT 2021
- FCO N/A
- Fundamental
- Price
- IOBT $1.29
- FCO $6.38
- Analyst Decision
- IOBT Strong Buy
- FCO
- Analyst Count
- IOBT 3
- FCO 0
- Target Price
- IOBT $9.33
- FCO N/A
- AVG Volume (30 Days)
- IOBT 233.4K
- FCO 100.1K
- Earning Date
- IOBT 08-12-2025
- FCO 01-01-0001
- Dividend Yield
- IOBT N/A
- FCO 14.96%
- EPS Growth
- IOBT N/A
- FCO N/A
- EPS
- IOBT N/A
- FCO 0.43
- Revenue
- IOBT N/A
- FCO N/A
- Revenue This Year
- IOBT N/A
- FCO N/A
- Revenue Next Year
- IOBT N/A
- FCO N/A
- P/E Ratio
- IOBT N/A
- FCO $12.30
- Revenue Growth
- IOBT N/A
- FCO N/A
- 52 Week Low
- IOBT $0.66
- FCO $4.73
- 52 Week High
- IOBT $1.73
- FCO $6.63
- Technical
- Relative Strength Index (RSI)
- IOBT 49.63
- FCO 61.80
- Support Level
- IOBT $1.26
- FCO $6.15
- Resistance Level
- IOBT $1.57
- FCO $6.43
- Average True Range (ATR)
- IOBT 0.13
- FCO 0.09
- MACD
- IOBT -0.04
- FCO 0.00
- Stochastic Oscillator
- IOBT 19.46
- FCO 82.11
About IOBT IO Biotech Inc.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.
About FCO abrdn Global Income Fund Inc.
abrdn Global Income Fund Inc is a closed-end, non-diversified management investment company. The Fund's principal investment objective is to provide high current income by investing predominantly in fixed-income securities. As a secondary investment objective, the Fund seeks capital appreciation, but only when consistent with its principal investment objective. It invests in Government Bonds & Corporate Bonds, and its investments are divided into three categories, Developed Markets, Investment Grade Developing Markets and Sub-Investment Grade Developing Markets.